Overview

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety of Neo-T in the treatment of advanced solid tumors. The secondary objective of this study is to evaluate preliminarily the effect of Neo-T in the treatment of advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
BGI, China
Collaborator:
Wuhan Union Hospital, China
Treatments:
Cyclophosphamide
Fludarabine
Interleukin-2